Neos Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Neos Therapeutics (NEOS) IPO Opens 21% Higher
July 23, 2015 10:29 AM EDTToday's IPO for Neos Therapeutics (NASDAQ: NEOS) opened for trading at $18.22 after pricing 4,800,000 shares of common stock at an initial public offering price of $15.00 per share.
UBS Investment Bank, BMO Capital Markets and RBC Capital Markets are acting as joint book-running... More
Neos Therapeutics (NEOS) Prices 4.8M Common Stock IPO at $15/Share, at Middle of Range
July 23, 2015 9:27 AM EDTNeos Therapeutics, Inc. ("Neos" or "the Company") (Nasdaq: NEOS) announced the pricing of its initial public offering of 4,800,000 shares of common stock at an initial public offering price of $15.00 per share. In addition, Neos has granted the underwriters a 30-day option to purchase up... More
